Chong Kun Dang Pharmaceutical Corp.(KR:185750)
â‚©62,000.00+1200.00 (+1.97%)
KR:185750
Chong Kun Dang Pharmaceutical Corp. financials statements
â‚©62,000.00
At close:+1200.00 (+1.97%)
Want to see KR:185750 full AI Analyst Report?
Chong Kun Dang Pharmaceutical Corp. (185750) Ratios
1 Followers
Chong Kun Dang Pharmaceutical Corp. Ratios
KR:185750's free cash flow for Q3 2026 was ₩108.67B. For the 2026 fiscal year, KR:185750's free cash flow was increased by ₩22.19B and operating cash flow was ₩86.48B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.12 | 2.61 | 1.85 | 1.91 | 2.08 |
| Quick Ratio | 1.28 | 1.65 | 1.34 | 1.19 | 1.38 |
| Cash Ratio | 0.42 | 0.62 | 0.43 | 0.31 | 0.41 |
| Solvency Ratio | 0.15 | 0.26 | 0.43 | 0.23 | 0.15 |
| Operating Cash Flow Ratio | 0.13 | 0.17 | 0.62 | 0.18 | 0.04 |
| Short-Term Operating Cash Flow Coverage | 0.41 | 0.97 | 1.75 | 0.55 | 0.13 |
| Net Current Asset Value | â‚© 297.88B | â‚© 399.77B | â‚© 359.78B | â‚© 210.02B | â‚© 186.26B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.13 | 0.16 | 0.21 | 0.23 |
| Debt-to-Equity Ratio | 0.37 | 0.21 | 0.27 | 0.38 | 0.42 |
| Debt-to-Capital Ratio | 0.27 | 0.17 | 0.21 | 0.27 | 0.30 |
| Long-Term Debt-to-Capital Ratio | 0.16 | 0.11 | 0.04 | 0.15 | 0.19 |
| Financial Leverage Ratio | 1.79 | 1.63 | 1.72 | 1.81 | 1.85 |
| Debt Service Coverage Ratio | 0.72 | 2.13 | 1.36 | 0.92 | 0.72 |
| Interest Coverage Ratio | 12.03 | 11.96 | 26.60 | 16.05 | 23.51 |
| Debt to Market Cap | 0.33 | 0.15 | 0.14 | 0.26 | 0.20 |
| Interest Debt Per Share | 28421.80 | 14832.51 | 18001.64 | 19804.47 | 19379.72 |
| Net Debt to EBITDA | 1.21 | -0.27 | 0.00 | 0.86 | 0.93 |
| Profitability Margins | |||||
| Gross Profit Margin | 30.56% | 33.57% | 39.67% | 36.46% | 36.90% |
| EBIT Margin | 4.76% | 6.95% | 15.02% | 6.99% | 6.34% |
| EBITDA Margin | 7.41% | 9.46% | 17.23% | 9.24% | 8.38% |
| Operating Profit Margin | 4.76% | 6.27% | 14.77% | 7.38% | 7.05% |
| Pretax Profit Margin | 4.82% | 6.43% | 14.47% | 6.53% | 6.00% |
| Net Profit Margin | 4.60% | 6.88% | 12.73% | 5.44% | 3.18% |
| Continuous Operations Profit Margin | 4.60% | 7.02% | 12.80% | 5.37% | 3.15% |
| Net Income Per EBT | 95.31% | 106.92% | 87.96% | 83.32% | 53.01% |
| EBT Per EBIT | 101.35% | 102.56% | 97.97% | 88.41% | 85.05% |
| Return on Assets (ROA) | 4.32% | 7.48% | 15.15% | 7.20% | 4.08% |
| Return on Equity (ROE) | 7.75% | 12.20% | 26.05% | 13.01% | 7.55% |
| Return on Capital Employed (ROCE) | 6.27% | 9.12% | 27.68% | 14.64% | 13.04% |
| Return on Invested Capital (ROIC) | 5.30% | 8.58% | 20.27% | 10.34% | 6.01% |
| Return on Tangible Assets | 4.60% | 7.89% | 15.74% | 7.37% | 4.16% |
| Earnings Yield | 7.13% | 9.25% | 13.63% | 8.88% | 3.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.62 | 5.29 | 5.36 | 5.30 | 6.60 |
| Payables Turnover | 5.52 | 5.27 | 5.48 | 6.50 | 6.55 |
| Inventory Turnover | 2.74 | 2.98 | 3.85 | 3.50 | 3.77 |
| Fixed Asset Turnover | 3.87 | 4.95 | 5.22 | 4.79 | 4.49 |
| Asset Turnover | 0.94 | 1.09 | 1.19 | 1.32 | 1.28 |
| Working Capital Turnover Ratio | 2.89 | 3.08 | 4.31 | 4.34 | 4.29 |
| Cash Conversion Cycle | 131.99 | 122.28 | 96.18 | 117.00 | 96.38 |
| Days of Sales Outstanding | 64.98 | 69.05 | 68.10 | 68.90 | 55.31 |
| Days of Inventory Outstanding | 133.14 | 122.55 | 94.74 | 104.24 | 96.76 |
| Days of Payables Outstanding | 66.12 | 69.32 | 66.66 | 56.13 | 55.68 |
| Operating Cycle | 198.11 | 191.60 | 162.84 | 173.13 | 152.07 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5112.60 | 4853.47 | 25006.67 | 5529.80 | 1037.29 |
| Free Cash Flow Per Share | -5577.61 | -136.89 | 19598.67 | 1197.63 | -3130.27 |
| Dividend Paid and CapEx Coverage Ratio | 0.44 | 0.81 | 3.96 | 1.05 | 0.21 |
| Capital Expenditure Coverage Ratio | 0.48 | 0.97 | 4.62 | 1.28 | 0.25 |
| Operating Cash Flow Coverage Ratio | 0.18 | 0.34 | 1.45 | 0.29 | 0.05 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.04 | 0.19 | 0.05 | 0.01 |
| Free Cash Flow Yield | -6.73% | -0.15% | 15.99% | 1.61% | -3.26% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.09 | 10.85 | 7.34 | 11.27 | 27.92 |
| Price-to-Sales (P/S) Ratio | 0.65 | 0.74 | 0.93 | 0.61 | 0.89 |
| Price-to-Book (P/B) Ratio | 1.09 | 1.32 | 1.91 | 1.47 | 2.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.86 | -650.16 | 6.25 | 62.18 | -30.63 |
| Price-to-Operating Cash Flow Ratio | 16.21 | 18.34 | 4.90 | 13.47 | 92.44 |
| Price-to-Earnings Growth (PEG) Ratio | -0.50 | -0.21 | 0.05 | 0.10 | -0.49 |
| Enterprise Value Multiple | 9.92 | 7.59 | 5.42 | 7.49 | 11.53 |
| Enterprise Value | 1.24T | 1.14T | 1.56T | 1.03T | 1.30T |
| EV to EBITDA | 9.92 | 7.59 | 5.42 | 7.49 | 11.53 |
| EV to Sales | 0.73 | 0.72 | 0.93 | 0.69 | 0.97 |
| EV to Free Cash Flow | -16.92 | -627.93 | 6.25 | 70.24 | -33.33 |
| EV to Operating Cash Flow | 18.46 | 17.71 | 4.90 | 15.21 | 100.59 |
| Tangible Book Value Per Share | 68223.79 | 61960.94 | 59978.62 | 48521.17 | 43810.62 |
| Shareholders’ Equity Per Share | 76186.31 | 67489.72 | 64111.80 | 50811.75 | 45499.19 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.05 | -0.09 | 0.12 | 0.18 | 0.47 |
| Revenue Per Share | 128455.71 | 119766.78 | 131211.54 | 121507.45 | 108003.16 |
| Net Income Per Share | 5907.15 | 8234.40 | 16703.70 | 6608.98 | 3434.11 |
| Tax Burden | 0.95 | 1.07 | 0.88 | 0.83 | 0.53 |
| Interest Burden | 1.01 | 0.92 | 0.96 | 0.93 | 0.95 |
| Research & Development to Revenue | 0.09 | 0.09 | 0.08 | 0.12 | 0.12 |
| SG&A to Revenue | 0.08 | 0.09 | 0.08 | 0.08 | 0.08 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.87 | 0.58 | 1.49 | 0.85 | 0.30 |
Currency in KRW

